Dr Rosemary Fisher joined Charing Cross and Westminster Medical School in 1989 having completed her PhD at the Institute of Cancer Research and in 1995 was appointed as a lecturer in Genetics. In 1998 she joined Imperial College as a research fellow to investigate recurrent molar pregnancies. Dr Fisher has considerable experience in medical education, having previously taught all aspects of clinical genetics and is currently involved in teaching and supervision of BSc and MSc students. She has an interest in both oncology – why some molar pregnancies become malignant - and reproductive medicine - understanding recurrent molar pregnancies. She was awarded Fellowship of the Royal College of Pathologists in 2004 and is currently an honorary consultant geneticist in Imperial College Healthcare NHS with responsibility for genetic diagnosis of trophoblastic tumours and recurrent molar pregnancies.
et al., ABC transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942., Oncogene, ISSN:0950-9232
et al., 2019, A case of intraplacental gestational choriocarcinoma; characterised by the methylation pattern of the early placenta and an absence of driver mutations, Bmc Cancer, Vol:19, ISSN:1471-2407
et al., 2019, Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours, British Journal of Cancer, Vol:120, ISSN:0007-0920, Pages:587-594
et al., 2019, Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?, European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol:234, ISSN:0301-2115, Pages:117-119
et al., 2019, The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia, European Journal of Cancer, Vol:109, ISSN:0959-8049, Pages:162-171